Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial
新辅助治疗方案:cobimetinib 和 atezolizumab 联合或不联合 vemurafenib 治疗 III 期黑色素瘤:NeoACTIVATE 试验的结果及微生物组的影响
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011706
Block, Matthew S; Nelson, Garth D; Chen, Jun; Johnson, Stephen; Yang, Lu; Flotte, Thomas James; Grewal, Eric P; McWilliams, Robert R; Kottschade, Lisa A; Domingo-Musibay, Evidio; Markovic, Svetomir N; Dimou, Anastasios; Montane, Heather N; Piltin, Mara A; Price, Daniel L; Khariwala, Samir S; Hui, Jane Yuet Ching; Erskine, Courtney L; Strand, Carrie A; Zahrieh, David; Dong, Haidong; Hieken, Tina J